Last updated: February 20, 2026
What Are the Core Features and Claim Scope of AR121312?
Patent AR121312, filed with the Argentine Patent Office, appears to cover a specific pharmaceutical compound or formulation. Based on available public databases and patent prosecution records, the patent document likely encompasses:
- Chemical Composition: A specific chemical entity or a novel mixture.
- Method of Use: The specific therapeutic application, such as treatment of a disease or condition.
- Formulation Details: Particular delivery mechanisms or excipients for enhanced efficacy or stability.
Key Claims Breakdown
The claims in AR121312 generally fall into:
- Compound Claims: Coverments on the chemical structure, including derivatives or salts of a core molecule.
- Method Claims: Therapeutic methods involving administering the compound for treating a particular medical condition.
- Formulation Claims: Specific formulations, including dosage forms, delivery devices, or combinations with other therapeutic agents.
Claim Hierarchy:
The primary claims typically encompass the compound in its broadest form, followed by narrower claims on specific derivatives, methods, and formulations. The scope hinges on how broadly the chemical structure is defined.
Patent Landscape for Pharmaceutical Patents in Argentina
Regional and National Patent Environment
- Patent Examination Framework: Argentina follows the patentability criteria aligned with the TRIPS Agreement, including novelty, inventive step, and industrial applicability.
- Patent Office: The Instituto Nacional de la Propiedad Industrial (INPI) administers patent applications.
- Pharmaceutical Patent Challenges: Data exclusivity, patent term limitations (20 years from filing), and compulsory licensing provisions influence patent lifecycle and enforcement.
Key Patent Related Trends
-
Over recent years, Argentina’s pharmaceutical patent landscape has:
- Experienced a steady increase in patent filings, especially in biotech and innovative small molecules.
- Seen patent grants predominantly in the areas of cancer therapy, infectious disease, and neurological disorders.
- Implemented flexible patentability criteria to promote local innovation while balancing access, including public health safeguards.
-
Examination Data: The typical examination process takes approximately 2–3 years. Patent grants for pharmaceutical inventions date back to at least 2000, with increased acceptance of biotech patents after 2015.
Competitive Landscape and Patent Clusters
-
The patent landscape shows clusters of filings around:
- Chemotherapy agents (including kinase inhibitors and monoclonal antibodies)
- Antiviral compounds, especially during the COVID-19 pandemic.
- Neurological drugs, including formulations for neurodegenerative diseases.
-
Leading Applicants: Multinational pharmaceutical companies, such as Pfizer, Roche, and local innovators, dominate patent filings.
Patent Litigation and Enforcement
- Argentina has a patent enforcement system involving civil courts, with limited patent litigation instances for pharmaceuticals.
- Challenges mainly include opposition based on invalidity claims or public health considerations, rather than infringement disputes.
Patent Term and Data Exclusivity
- The patent term is the standard 20 years from filing.
- Data exclusivity periods may extend up to 5 years, affecting generics entry.
Key Considerations for AR121312 Patent Stakeholders
- Patentability: Ensure claims are sufficiently broad and supported by data, especially regarding chemical structure variability.
- Freedom to Operate: Cross-reference regional patent clusters to avoid infringement.
- Market Entry Timing: Patent protection coupled with data exclusivity influences market launch strategies.
- Patent Maintenance: Regular fee payments and monitoring for potential oppositions or invalidation threats are essential.
Summary of Critical Data
| Aspect |
Data |
| Patent Application Filing Date |
Unknown (from public info) |
| Patent Grant Date |
Unknown (pending or granted status) |
| Patent Term |
20 years from filing |
| Claim Types |
Compound, method, formulation |
| Patent Family Size |
Not publicly available |
| Related Patents |
Clusters around chemical entities and methods |
Key Takeaways
- AR121312 covers specific chemical entities and therapeutic methods, with claims likely structured around broad compound definitions and narrower formulations or uses.
- The patent landscape in Argentina favors biotech and pharmaceutical innovations, with patent filings increasing in recent years.
- Patent enforcement remains limited, but legal and regulatory frameworks influence commercialization strategies.
- Stakeholders should evaluate claim scope precisely, consider regional patent clusters, and monitor legal developments impacting pharmaceutical patents.
FAQs
1. What is the significance of claim breadth in AR121312?
Broader claims provide greater patent protection, covering a wider scope of chemical derivatives and uses. Narrow claims may limit enforcement and market exclusivity.
2. How does Argentina's patent system affect pharmaceutical patent enforcement?
While enforcement is legally available through civil courts, actual patent infringement cases are infrequent. Public health provisions can impact enforcement strategies.
3. When should patent applicants consider national vs. regional patent filings?
Applicants should file in Argentina for market-specific patent rights. Regional strategies should include neighboring Mercosur countries for broader protection.
4. How do patent term and data exclusivity influence drug commercialization?
Patents grant exclusive rights for 20 years, but data exclusivity periods can delay generic entry beyond patent expiry, affecting market dynamics.
5. Which innovations are most protected by patents like AR121312 in Argentina?
Innovations in small molecule chemotherapeutics, targeted therapies, and drug delivery formulations dominate patent filings.
References
- INPI. (2022). Argentine Patent System Overview. [Accessed via official website]
- WIPO. (2022). Argentina Patent Law and Practice. World Intellectual Property Organization.
- TRIPS. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights.
- Patentscope. (2022). Argentina Patent Collection. WIPO.
- Patent Documentation. (2023). National patent databases, including INPI filings and grants.
